March 12--It took less than a year for the Ebola drug ZMapp to go from initial development to use, on an emergency basis, in humans, Hugh Haydon, CEO of Kentucky BioProcessing said Wednesday.
That's just one of the tidbits he shared...
March 12--It took less than a year for the Ebola drug ZMapp to go from initial development to use, on an emergency basis, in humans, Hugh Haydon, CEO of Kentucky BioProcessing said Wednesday.
That's just one of the tidbits he shared...
March 12--It took less than...